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F4 enterotoxigenic Escherichia coli (ETEC) cause diarrhoea and mortality in piglets leading to severe economic
losses. Oral immunization of piglets with F4 fimbriae induces a protective intestinal immune response evidenced by
an F4-specific serum and intestinal IgA response. However, successful oral immunization of pigs with F4 fimbriae in
the presence of maternal immunity has not been demonstrated yet. In the present study we aimed to evaluate the
effect of maternal immunity on the induction of a systemic immune response upon oral immunization of piglets.
Whereas F4-specific IgG and IgA could be induced by oral immunization of pigs without maternal antibodies
and by intramuscular immunization of pigs with maternal antibodies, no such response was seen in the orally
immunized animals with maternal antibodies. Since maternal antibodies can mask an antibody response, we also
looked by ELIspot assays for circulating F4-specific antibody secreting cells (ASCs). Enumerating the F4-specific
ASCs within the circulating peripheral blood mononuclear cells, and the number of F4-specific IgA ASCs within the
circulating IgA+ B-cells revealed an F4-specific immune response in the orally immunized animals with maternal
antibodies. Interestingly, results suggest a more robust IgA booster response by oral immunization of pigs with than
without maternal antibodies. These results demonstrate that oral immunization of piglets with F4-specific maternal
antibodies is feasible and that these maternal antibodies seem to enhance the secondary systemic immune response.
Furthermore, our ELIspot assay on enriched IgA+ B-cells could be used as a screening procedure to optimize mucosal
immunization protocols in pigs with maternal immunity.Introduction
F4 fimbriated enterotoxigenic E. coli (F4+ ETEC) are one
of the main pathogens causing neonatal and post-weaning
diarrhoea leading to severe economic losses in the pig in-
dustry due to mortality, growth retardation and medication
costs. ETEC adhere with their F4 fimbriae to intestinal F4-
specific receptors resulting in colonization of the small
intestine and release of enterotoxins. Neonatal diarrhoea is
prevented by vaccination of sows, which will then protect
their offspring by ETEC-specific lactogenic antibodies
[1,2]. As at weaning piglets are suddenly deprived of these
passive antibodies, active mucosal immunity should be
elicited. To induce intestinal immunity, oral immunization* Correspondence: Nguyen.VanUt@UGent.be
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creativecommons.org/publicdomain/zero/1.0/is most suited; for instance, oral immunization of F4R+ F4-
seronegative piglets resulted in the induction of a protect-
ive immunity [3]. However, the presence of ETEC-specific
neutralizing lactogenic antibodies may interfere with the
induction of immune responses to orally administered vac-
cines [4,5]. Even deprived of milk antibodies in the gut at
weaning, maternal IgG is often still present in serum [6].
Some studies showed that maternally derived serum anti-
bodies can suppress the induction of an immune responses
[4,7], whereas others claim the potential of such antibodies
to prime immunity via bidirectional transport by neonatal
Fc receptors (FcRn) on porcine enterocytes [8,9]. Conse-
quently, it remains to be demonstrated if conventionally
reared pigs with maternal F4-specific serum antibodies can
be orally immunized with F4 fimbriae. The presence of ma-
ternal antibodies might interfere with the oral induction of
an immune response, and could also hamper the detectionarticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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ways to measure an immune response were explored in
this study, using a similar strategy described in Saletti et al.
[10]. Results indicate that the combination of an ELIspot
assay with immunomagnetic enrichment of IgA+ B cells
was most sensitive to monitor the immune response upon
oral immunization of piglets with soluble F4 fimbriae in
the presence of maternal F4-specific serum antibodies and
demonstrate an immune response in the animals orally im-
munized in the presence of maternal antibodies.
Materials and methods
Selection of pigs
Fifteen, 3- to 4-week-old, Belgian Landrace x Pietrain
piglets were selected from three farms. On two of these
farms primiparous and multiparous sows were vacci-
nated against neonatal ETEC infections using Porcilis
Porcoli Diluvac Forte (F4ab, F4ac, F5 and F6). Piglets
were screened for the presence of F4-specific serum
antibodies and positive animals were tested for the ab-
sence of F4-specific antibody-secreting cells (ASCs) to
assure that the F4-specific serum antibodies were of ma-
ternal origin. Furthermore, all piglets were genotyped for
MUC4 as previously described [11] to evaluate the F4
receptor status. The MUC4 homozygous and heterozy-
gous genotypes are positive in the in vitro villous adhe-
sion assay for F4ac E. coli binding indicating they
express the F4acR [11,12].
Four seronegative and 11 seropositive animals, all het-
erozygous for MUC4 and without F4-specific ASCs were
still suckling when tested. They were weaned and imme-
diately transported to isolation units with water and feed
ad libitum. To prevent E. coli infections upon weaning,
animals were treated orally with colistin for five con-
secutive days (150 000 U/kg body weight/day; ProMy-
cine® Pulvis, VMD, Arendonk, Belgium) until two days
before the immunization. Experimental and animal man-
agement procedures were approved by the animal care
and ethics committee of the Faculty of Veterinary Medi-
cine (EC2010/042).
Immunization and sampling
The animals were divided into 4 groups, which were
housed separately: two groups were orally immunized
with 1 mg F4ac fimbriae in 10 mL phosphate buffered
saline (PBS) on three consecutive days and once again
14 days post primary immunization (dppi), a group of
four piglets without F4-specific maternal antibodies
(seronegative-oral group), and a group of six piglets with
F4-specific maternal antibodies (maternal-oral group). A
third group of two pigs with F4-specific maternal anti-
bodies was intramuscularly immunized with 100 μg F4ac
fimbriae emulsified with incomplete Freund’s adjuvant
on 0 and 14 dppi (maternal-IM group) and a fourthgroup of three pigs with F4-specific maternal antibodies
received PBS orally (the maternal-PBS group).
The F4ac fimbriae, purified from the enterotoxigenic
E. coli strains GIS26 (O149:K91, F4ac+, LT+STa+STb+),
were used for the immunizations, whereas those from
strain IMM01 were used to measure the antibody re-
sponses in ELISA and ELIspot assays. Isolation and puri-
fication of the fimbriae occurred as previously described
[13]. Blood was sampled from the external jugular vein
at 0, 9, 14, and 21 dppi in tubes with heparin (50 units/
mL blood, LEO Pharma N.V/S.A, Belgium) to determine
the kinetics of the F4-specific ASCs and without heparin
to determine the F4-specific serum antibody response.
At 21 dppi animals were euthanized using pentobarbital
(Kela, Hoogstraten, Belgium) and villi were collected
from a mid-jejunal segment (15 cm) to confirm the F4
receptor status using the in vitro villous adhesion assay
as previously described [14].
F4-specific serum antibody ELISA
Serum samples were heat-inactivated,kaolin-treated and
tested in ELISA for F4ac-specific serum antibodies as pre-
viously described [14] with slight modifications. A 96-well
microtiter plate (Maxisorp, Life Technologies, Merelbeke,
Belgium) was coated with 1 μg/mL (in PBS) F4ac-specific
monoclonal antibody (mAb; IMM01) [15] or with 5 μg/mL
F4ac fimbriae (strain IMM01) to detect total F4-specific
antibodies or F4-specific IgG and IgA antibodies, respect-
ively. After 2 h incubation at 37 °C, remaining binding sites
were blocked for 1 h at 37 °C with PBS + 0.2% Tween® 80.
To detect total F4-specific antibodies, consecutively F4ac
fimbriae (GIS26) (25 μg/mL in PBS + 0.2% Tween®20 + 3%
bovine serum albumin),two-fold serial dilutions of the sera
and cross-adsorbed HRP-conjugated anti-pig IgG antibody
(Bethyl Laboratories, Montgomery, TX, USA) were each
added for 1 h at 37 °C. To detect F4-specific antibody sub-
classes, consecutively the treated sera, mouse anti-swine
IgG or IgA mAbs (clones 27.8.1 and 28.4.1, respectively;
[16]) and HRP-conjugated anti-mouse IgG antibody
(Bethyl Laboratories) were each added for 1 h at 37 °C. Be-
tween each incubation step plates were washed three times
with PBS + 0.2% Tween®20 (PBS-T). Then, ABTS (Roche,
Mannheim, Germany) was added and after 30 min at 37 °C
the optical density was measured at 405 nm. The cut-off
values were calculated as the mean optical density at
405 nm of sera from all F4-seronegative pigs at day 0 in-
creased with 3 times the standard deviation. The titer was
the inverse of the highest dilution with an optical density
higher than the calculated cut-off value.
Enrichment of circulating IgA+ B-cells
Peripheral blood mononuclear cells (PBMC) were isolated
from 20 mL heparinized blood by density gradient centri-
fugation on Lymphoprep® (Axis-Shield, Oslo, Norway)
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cytes were lysed with ammonium chloride (0.8%, w/v) for
10 min. The cells were pelleted (350 g, 10 min, 4 °C),-
resuspended in PBS with 1 mM EDTA (Sigma-Aldrich,
Steinheim, Germany; PBS-EDTA) and the viable cell con-
centration was determined. To select IgA+ cells, 3.0 × 108
PBMCs were incubated on ice for 20 min with biotinyl-
ated polyclonal goat anti-pig IgA antibodies (Abcam,
Cambridge, UK). Thereafter, cells were washed twice with
PBS-EDTA, incubated with mouse anti-biotin mAb-
conjugated microbeads (isotype IgG1; Miltenyi Biotec,
Bergisch Gladbach, Germany) for 15 min on ice and re-
suspended in 5 mL PBS-EDTA supplemented with 1%
fetal calf serum (FCS, Life Technology) (MACS-buffer).
The cell suspension was brought into a LS column (Milte-
nyi Biotec) and placed into a QuadroMACS™ separation
unit (Miltenyi Biotec). The IgA+ cells were eluted with
5 mL MACS-buffer following removal of the column from
the magnetic field. The obtained IgA+ fraction, approxi-
mately 2-4% of the PBMC, was resuspended at 5.0 × 106
cells/mL in complete medium (RPMI 1640 supplemented
with 100 μg/mL kanamycine, 5% FCS, 100 U/mL penicilin
and 100 μg/mL streptomycin, 1% non-essential amino
acids, 1 mM sodium pyruvate (all from Life Technology),
2 mM L-glutamine (Sigma-Aldrich)).
Detection of F4-specific ASCs
The number of F4-specific ASCs was determined as
previously described [14] with slight modifications. A
96-well microtiter plate was coated with F4-specific
mAbs for total F4-specific ASC detection or with F4ac
fimbriae for F4-specific IgA+ ASC detection as for the
ELISA assay. Subsequently, 5.0 × 105 PBMCs or IgA+
cells in 100 μL complete medium were added overnight
at 37 °C in a humidified 5% CO2 atmosphere. Thereafter,
the cells were removed by washing 10 times with PBS-T.
To detect total F4-specific ASCs, the plates were
incubated for 1 h at 37 °C with cross-adsorbed HRP-
conjugated mouse anti-pig IgG (1:5000; Bethyl Labora-
tories). To detect F4-specific IgA+ ASCs, the plates
were incubated for 1 h at 37 °C with anti-swine IgA
mAb (clone 27.8.1) followed by an incubation for 1 h at
37 °C with HRP-conjugated anti-mouse IgG antibody
(1:1000; Bethyl Laboratories). To visualize spots, 50 μL
3,3’,5,5’-tetramethylbenzidine liquid substrate (Sigma-
Aldrich) was applied for 15 min at room temperature.
The resulting spots were scanned with an Immuno-
Spot® analyzer (CTL-Europe GmbH, Germany). For
each condition spots in 8 wells (5.0 × 105 cells/well)
were counted to obtain the number of F4-specific total
or IgA+ ASCs per 4.0 × 106 PBMCs or F4-specific IgA+
ASCs per 4.0 × 106 IgA+ cells. Results were normalized
to 3.0 × 108 PBMCs, the average number of PBMCs iso-
lated from 20 mL blood.Statistical analysis
The differences in F4-specific antibody log2 titers and in
numbers of F4-specific ASCs, after square root trans-
formation to homogenize variances, were analyzed be-
tween groups at one time point or within a group
between different time points. Analysis occurred with
GraphPad Prism version 5.0c for Mac OS X using one-
way ANOVA with Tukey’s post hoc test. The equal vari-
ances of the data were verified by Levene’s test. A
p-value <0.05 was considered statistically significant.
Data are presented as mean ± SEM.
Results
Maternal immunity obscures or suppresses serum
antibody responses following oral immunization
Before immunization,F4-specific IgG titers of pigs with
maternal antibodies were significantly higher than those of
F4-seronegative pigs (p < 0.01) (Figure 1A), In the
maternal-PBS and the maternal-oral group, the IgG titers
gradually declined in time, whereas in the maternal-IM
group and the seronegative-oral group the IgG titer sig-
nificantly increased from 0 to 21 dppi upon intramuscular
or oral immunization, respectively (p < 0.05). Furthermore,
the IgG titer in the maternal-IM group at 21 dppi was sig-
nificantly higher compared to the maternal-PBS (p < 0.05)
and the maternal-oral group (p < 0.01) (Figure 1A).
F4-specific IgA titers were similarly low in all 4 groups
before immunization (Figure 1B). After immunization an
increase in F4-specific IgA occurred in the intramuscularly
immunized pigs with maternal antibodies and the orally
immunized seronegative pigs. However, only in the latter this
increase was statistically significant (p < 0.05) (Figure 1B).
Maternal immunity enhances circulating F4-specific
IgA+ ASC upon oral immunization
The above results suggested that maternal antibodies ei-
ther suppress or mask the immune response following
oral immunization. If true this should be reflected in the
circulating F4-specific ASCs after immunization. When
looking at the total F4-specific ASCs only significant in-
creases were seen in the orally immunized seronegative
animals and the intramuscularly immunized animals hav-
ing maternal antibodies (Figure 1C). However, the primary
responses seen with the ELIspot assay in both groups were
clearly more obvious than when measuring the serum
antibody responses. Furthermore, in the orally immunized
pigs having maternal antibodies, an insignificant increase
was seen in the F4-specific ASCs, similar to the increase
in pigs without maternal antibodies (Figure 1C).
F4-specific secretory IgA induced at the gut-associated
lymphoid tissue is critical to protect piglets against F4+
ETEC infections [14,17]. Therefore, the number of cir
culating F4-specific IgA+ ASCs in the PBMC fraction
was determined. However, the number of spots in each
A C
B D
Figure 1 The immune response of pigs after immunization with F4 fimbriae. The F4-specific IgG antibody responses (A), the F4-specific IgA anti-
body responses (B), number of F4-specifc total antibody secreting cells (ASCs) per 3.0 × 108 peripheral blood monomorphonuclear cells (PBMCs) (C),
number of F4-specific IgA+ ASCs per 3.0 × 108 PBMCs (D). Piglets were immunized with F4 fimbriae at day 0 and at 14 days post primary immunization
(dppi). Data are presented as the mean ± SEM. The asterisk indicates a statistical significant difference (p < 0.05) within a group between a time point
and day 0, while letters indicate a statistical significance (p < 0.05) between groups at a designated time point; (A) in comparison to the maternal-PBS
group, (b) to the seronegative-oral group. ↑, immunization time points.
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dppi per 5.0 × 105 PBMCs) was too low to allow a proper
analysis. This is demonstrated in Figure 2A (left); only one
F4-specific spot can be seen in 5.0 × 105 PBMCs at 21 dppi
of an orally immunized pig with maternal antibodies. In
4 × 106 PBMCs (=8 wells) of the maternal-PBS,maternal-
oral,maternal-IM,seronegative-oral groups, 0.82, 5.3, 1.8
and 7 F4-specific IgA+ ASCs were found, respectively
(Figure 2B). These numbers show no significant difference
between groups. To enhance the sensitivity of the ELIspot
assay for detecting IgA+ B cells, these cells were enriched
from the PBMC fraction. In the representative picture in
Figure 2A (right), 18 F4-specific spots were detected in
5.0 × 105 enriched IgA+ B-cells. On average we could de-
tect 4, 55.7, 35.8 and 28.5 F4-specific IgA+ ASCs within4.0 × 106 enriched IgA+ B-cells of the maternal-PBS,
maternal-oral,maternal-IM,seronegative-oral pigs, respect-
ively (Figure 2B). Thus, the enrichment increased the sen-
sitivity of the F4-specific ELIspot assay and as such
enabled the detection of differences between the groups.
As a result, the ELIspot assay on the enriched IgA+ cells
revealed a clearly significant IgA response in the maternal-
IM group at 21 dppi (p < 0.001) (Figure 1D). This response
was similar to the F4-specific serum IgA response
(Figure 1B). Also in both oral immunization groups, the
ELIspot assay on the enriched IgA+ cells revealed a sig-
nificant increase in IgA+ ASCs at 9 (p < 0.05) and 21 dppi
(p < 0.001) (Figure 1D). Interestingly, the primary IgA+
ASC response upon oral immunization was similar in pigs
with or without maternal antibodies (73.5 ± 43.8 spots and
Figure 2 The efficiency of using ELISpot on enriched IgA+ B-cell fractions to enumerate F4-specific IgA+ antibody secreting cells (ASCs). A In
one well, only one F4-specific IgA+ ASC was detected from 5 × 105 peripheral blood monomorphonuclear cells (PBMCs) (left) while 18 F4-specific
spots were detected from 5 × 105 enriched IgA+ B-cells (right) at 21 days post primary immunization (dppi) of an oral immunized pig having
maternal antibodies; each blue spot is counted as one F4-specific IgA+ ASC. B From eight wells, less than seven F4-specific IgA+ ASCs were detected
from 4.0 × 106 PBMCs whereas more than 28 F4-specific IgA+ ASCs were detected from 4.0 × 106 enriched IgA+ B-cells at 21 dppi of the three
immunized groups. The asterisk indicates a statistical significant difference (p < 0.05) between groups in comparison to the maternal-PBS group.
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whereas the secondary immune response was higher in
the group with maternal antibodies than without (164 ± 28
spots versus 79 ± 16 spots per 3.0 × 108 PBMCs) and even
higher than in the IM immunized pigs (96 ± 1 spots per
3.0 × 108 PBMCs), although these were not significantly
different. Thus, in the orally immunized pigs the F4-
specific IgA+ ASC response did not mimic the F4-specific
serum IgA response (Figure 1B).
Intriguingly, the pattern of total F4-specific ASCs
(Figure 1C) and F4-specific IgA+ ASCs (Figure 1D) within
the maternal-IM group is clearly different. In this group,
the number of total F4-specific ASCs is significantly
higher at 9 dppi as compared to the control group, while
the number of F4-specific IgA+ ASCs only increased at21 dppi. This confirms that intramuscular immunization
induces less IgA+ ASCs as compared to the other antibody
subclass ASCs.
Discussion
We demonstrated previously that oral immunization of
F4-seronegative, F4 receptor positive (F4R+) with F4 fim-
briae resulted in weak F4-specific IgG and IgA re-
sponses, which are boosted by a second immunization
and lead to a protective immunity against an F4+ ETEC
infection [3]. However, F4+ ETEC infections are highly
prevalent and most sows are immune against this infec-
tion [2] so that most piglets obtain F4-specific antibodies
via colostrum and milk. The immune response upon
immunization in F4R+ piglets with passive immunity
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serum antibody response was observed in pigs orally im-
munized in the presence of high titers of F4-specific ma-
ternal antibodies. These antibodies can obscure serum
antibody responses or even suppress mucosal B cell re-
sponses, as shown in gnotobiotic pigs with high titers
of passive serum antibodies against rotavirus [4,7]. To
elucidate if maternal immunity masks or suppresses
the serum antibody response in our study, a detection
method was developed to discriminate active from pas-
sive immunity. Using ELIspot assays on PBMCs, we have
previously shown that F4-specific ASC responses of or-
ally immunized F4-seronegative pigs peaked in blood
around 9 dppi [14]. In the present study, the ELIspot
methodology allowed detecting immune responses in
pigs orally immunized in the presence of F4-specific ma-
ternal antibodies. Interestingly, a similar response was
observed in pigs with or without maternal antibodies in-
dicating that passive immunity did not suppress the oral
immunization. Since mainly sIgA is responsible for pro-
tection against an intestinal pathogen [14], the number
of F4-specific IgA+ ASCs within the PBMC fraction was
determined. Unfortunately, this number was too low to
properly evaluate the immune response, due to the low
frequency of antigen-specific ASC in peripheral blood as
compared to mucosal tissues [18,19]. To evaluate muco-
sal immune responses following oral vaccination, ELI-
spot assays were combined with an enrichment strategy
to increase its sensitivity [10,20]. Since IgA is the major
isotype induced in the small intestine upon oral vaccin-
ation, we chose to enrich the circulating IgA+ cell frac-
tion from blood. An alternative way might be to enrich
cells expressing the intestinal homing receptor α4ß7
[10]. This integrin binds to mucosal addressin cell adhe-
sion molecule-1 (MAdCAM-1), which is specifically
expressed on endothelial cells in the intestinal lamina
propria and the gut-associated lymphoid tissue [21].
However, not only B cells, but also gut-homing T cells
and eosinophils express α4ß7 [22,23]. In addition, by
enriching only the α4ß7+ cells, the immune response of
the IM immunized animals, which is important in this
study, would have been missed.
Comparing the ELISA and ELIspot assays confers some
interesting observations. In pigs with maternal antibodies,
the ELISA could only detect an F4-specific antibody re-
sponse in the IM immunized animals, whereas the ELIspot
assays also allowed detection of IgA+ B-cell response upon
oral immunization. Not only the secondary response, but
also the primary response was clearly observed. Further-
more, the ELIspot assay on enriched IgA+ B cells detected
more F4-specific IgA+ ASCs in the presence than in the
absence of maternal antibodies after the second oral
immunization. Enterocytes express the human neonatal Fc
receptor (FcRn), which bidirectionally transports IgG fromthe intestinal lumen to the underlying tissues [8,24]. Via
this transport, maternal IgG could reach the gut lumen,
bind antigen, and transport this back to the subepithelial
antigen presenting cells (APCs) as immune complexes,
leading to a priming of the immune system and protection
to a challenge infection [25]. In contrast to rodents, pig-
s,as most other species, express FcRn throughout live
[9,26,27]. We propose that FcRn transports the F4-specific
maternal IgG to the gut lumen, where it binds the orally
administered F4 fimbriae and transports the resulting
immune complexes back to the lamina propria. There
the immune complexes are endocytosed by antigen-
presenting cells, such as dendritic cells, which become acti-
vated and enhance the subsequent mucosal immune re-
sponse [28,29]. However, this effect is probably too weak to
be observed upon the primary immunization, but might
have improved priming in pigs with maternal antibodies,
resulting in a stronger secondary immune response. In con-
trast, no enhanced priming in the presence of passive im-
munity, but rather suppression of the immune response,
was observed in gnotobiotic pigs immunized with
rotavirus-like particles or infected with rotavirus, although
rotavirus-specific IgG appeared in intestinal fluid [2,5]. This
discrepancy could arise from differences in antibody titers,
an immature mucosal immune system in gnotobiotic pigs
and the complexity of viruses and virus-like particles in
comparison with soluble fimbriae.
It is know that maternal antibody titers interfere with
systemic immunizations and that the ratio maternal anti-
bodies/antigen is critical for this interference [30]. Look-
ing at the actual levels of maternal antibodies before
immunization in the maternal-oral group, titres were
160, 320, 320, 1280, 1280 and 2560. The number of F4-
specific IgA+ ASCs in pigs with the higher maternal
antibody levels reached similar amounts as those with a
lower maternal antibody level ranging between 131 and
251 F4-specific IgA+ ASC per 3.0 × 108 PBMCs, except
for the piglet with the titer of 2560, which showed the
lowest number F4-specific IgA+ ASCs after two immuni-
zations (52 per 3.0 × 108 PBMCs). Even though this low
response is in accordance with interference on the
immunization of high maternal antibody titers, such a
conclusion cannot be drawn from an observation in only
one animal
Noteworthy is the higher F4-specific serum IgA titer
after intramuscular boosting as compared to the orally
immunized animals, even though a smaller number of
F4-specific IgA+ ASCs were detected in the intramuscu-
larly immunized animals. Although the peak of the re-
sponse could have been missed due to different kinetics of
the ASC response following IM versus oral immunization,
preliminary experiments indicate this is unlikely. Presum-
ably, most F4-specific IgA+ ASCs induced by the IM
immunization home to systemic tissues, whereas those
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mucosa. In pigs, 31% of serum IgA originates from intes-
tinal synthesis, whereas approximately 26% of intestinal
IgA comes from serum [31]. Thus, measuring serum IgA
only shows a fraction of the real response in orally immu-
nized animals.
In conclusion, we clearly demonstrated that an active
immune response could be induced via oral immunization
of pigs with maternal antibodies. Results suggest that this
maternal immunity could even enhance the systemic im-
mune response to cognate antigen. Furthermore, results
suggest that measuring numbers of circulating antigen-
specific IgA+ ASCs within the IgA+ B-cells fraction from
PBMCs could identify small numbers of activated antigen-
specific B-cells and could be the method of choice to
evaluate mucosal immune responses in pigs with maternal
immunity following oral immunization.
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